search

Active clinical trials for "Hypertension"

Results 3211-3220 of 5863

A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine...

Open-Angle GlaucomaOcular Hypertension

The purpose of this study was to describe the ocular discomfort immediately upon instillation of Brinzolamide 1%/Brimonidine 0.2% Tartrate Ophthalmic Suspension, Brinzolamide 1% Ophthalmic Suspension, and Brimonidine Tartrate 0.2% Ophthalmic Solution in subjects with open-angle glaucoma and/or ocular hypertension.

Completed13 enrollment criteria

A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension

GlaucomaOpen-Angle1 more

This is a study of bimatoprost as initial, replacement, or adjunctive intraocular pressure (IOP)-lowering therapy in patients with primary open angle glaucoma and ocular hypertension.

Completed3 enrollment criteria

A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate...

Hypertension

The primary aim of the trial is to compare the influence of MICARDIS® (telmisartan 40-80 mg) and COZAAR® (losartan 50-100 mg) in lowering ambulatory diastolic blood pressure (DBP) during the last 6 hours of the 24-hour dosing interval as measured by ABPM after 8-weeks treatment. Secondary objectives include evaluations of: 1) change from baseline in mean systolic blood pressure (SBP) during the last 6 hours of the 24-hour dosing interval as measured by ABPM, 2) changes from baseline in SBP and DBP during other periods during the 24-hour ABPM profile, 3) changes from baseline in mean seated trough SBP and DBP as measured by manual cuff sphygmomanometer, and 4) responder rates based on both ABPM and trough cuff blood pressure

Completed35 enrollment criteria

Effects of Telmisartan by Ambulatory Blood Pressure Monitoring (ABPM) in Chinese Patients With Mild...

Hypertension

To assess the trough/peak ratio of 40 mg Telmisartan tablet by ambulatory blood pressure monitoring in Chinese patients with mild to moderate essential hypertension

Completed22 enrollment criteria

Pulmonary Arterial Denervation in Patients With Pulmonary Hypertension Associated With the Left...

Pulmonary Hypertension

A number of 100 patients with pulmonary hypertension associated with the left Heart failure scheduled for elective pulmonary arterial denervation (PADN) are randomized 1:1 to either PADN or control group.

Completed12 enrollment criteria

Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)

Hypertension

The STOP-Trial is a prospective multicenter nonrandomized open study on grade I hypertension, performed by General practitioners. The study will be conducted in parallel in the Clinical Investigation Center Plurithematic (CIC-P)1433 of Nancy (the study coordinating center) by the general practitioners investigators of the CIC-P. The main purpose of the study is to determine the factors associated with the rate of patients remaining normotensive one year after stopping their antihypertensive monotherapy or low dose dual therapy: white coat hypertension primary diagnosis by home blood pressure measurements (HBPM) /ambulatory blood pressure measurements (ABPM) /clinical measure initial blood pressure level compliance therapeutic class versus others age gender weight variation modification of lifestyle concomitant treatments and associated substances ... The primary endpoint will be the rate of normotensive patients at one year (i.e. HBPM values <135/85 mmHg).

Completed15 enrollment criteria

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fed Conditions

Hypertension

The objective of this study was to prove the bioequivalence of Losartan Potassium 100 tablet under fasted conditions.

Completed4 enrollment criteria

Treating to Target for Patients With Hypertension

Hypertension

Patients with poorly controlled hypertension will have improved hypertensive control with telephone coaching and with telephone coaching combined with home-titration of medications.

Completed5 enrollment criteria

To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg

AnginaHypertension

To demonstrate the relative bioavailability of atenolol tablets, 100 mg.

Completed3 enrollment criteria

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly...

Hypertension

This 14 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients 65 years of age or older with high blood pressure. The medication being tested has been approved by the FDA for the treatment of high blood pressure.

Completed12 enrollment criteria
1...321322323...587

Need Help? Contact our team!


We'll reach out to this number within 24 hrs